Use of tranexamic acid for prevention of coagulopathy during resection of brain tumor

Authors

  • Jorman H. Tejada
  • Carlos V. Rivas
  • Daniel Charry

DOI:

https://doi.org/10.31157/an.v21i3.124

Keywords:

tranexamic acid, meningioma, neurosurgery, resection

Abstract

Tranexamic acid (TXA) is a medication to priphylaxis use and excessive blood lost treat. As a consequience of CRASH 2 publishing earned itself an important área in the bleeding lost perioperative surgery field. A patient of 39 years old eith a big supratentorial tumor was taken to embolization without successful, using tranexamic acid such a bledding treatment clinic case.

Downloads

Published

2016-09-01

How to Cite

Tejada, J. H., Rivas, C. V., & Charry, D. (2016). Use of tranexamic acid for prevention of coagulopathy during resection of brain tumor. Archivos De Neurociencias, 21(3). https://doi.org/10.31157/an.v21i3.124

Issue

Vol. 21 No. 3 (2016)

Section

Case report

License

Copyright (c) 2016 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.